> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CMS proposes CY2027 rule raising ACO shared-savings rate, delaying 2025 reconciliation to November
- URL: https://members.americanhealthintel.com/2026-07-19-regulator/
- Published: 2026-07-20T13:37:08.000Z
- Updated: 2026-07-20T13:37:08.000Z
- Description: Plus: House E&C Committee to markup 29 bills including price transparency and prior-auth reform. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: House E&C Committee to markup 29 bills including price transparency and prior-auth reform. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Regulator Sunday, July 19, 2026 CMS proposes CY2027 rule raising ACO shared-savings rate, delaying 2025 reconciliation to November Plus: House E&C Committee to markup 29 bills including price transparency and prior-auth reform. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Rule Confidence: High CMS just proposed a rule for Medicare's accountable care organizations, the physician groups paid extra for controlling costs, that raises their bonus rate while delaying last year's payments to them until November. The proposed CY2027 rule raises the Medicare Shared Savings Program's Level E shared-savings rate from 50% to 60%, but a new retroactive spending guardrail pushes 2025 reconciliation payments to November 2026\. Comments due Sept 14. Why it matters This reshapes how Medicare's largest accountable care program splits savings, and if finalized it could delay payments many physician organizations were expecting this year. Sources: [Federal Register](https://www.federalregister.gov/documents/2026/07/16/2026-14327/medicare-and-medicaid-programs-cy-2027-payment-policies-under-the-physician-fee-schedule-and-other?ref=members.americanhealthintel.com) · [CMS](https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-medicare-physician-fee-schedule-proposed-rule?ref=members.americanhealthintel.com) Deadline Confidence: High A House committee, the panel that writes the rules for hospitals, insurers, and drugmakers, votes Monday on 29 bills covering price transparency, Medicare Advantage prior authorization, and faster generic biosimilar access. The House Energy and Commerce Committee's markup is 5pm ET July 20 in Rayburn 2123, open to the public and livestreamed. Bills include the Lower Costs, More Transparency Act and the Prior Authorization Accountability Act. Why it matters This is a legislative step, not law yet; watch which of the 29 bills clear committee since that signals what Congress may act on next. Sources: [House](https://energycommerce.house.gov/events/full-committee-markup-of-health-bills?ref=members.americanhealthintel.com) · [Tradersunion](https://tradersunion.com/news/financial-news/show/2701053-house-energy-commerce-committee-bill-markup/?ref=members.americanhealthintel.com) Also today FDA approves first oral pan-PI3K/mTOR inhibitor combo for metastatic breast cancer [Read](https://americanhealthintel.com/editions/2026-07-19-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#fda-gedatolisib-revtorpyk-breast-cancer) OIG issues first favorable advisory opinion on a food-as-medicine produce-voucher program [Read](https://americanhealthintel.com/editions/2026-07-19-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#oig-food-as-medicine-advisory-opinion-26-16) Arkansas pathology lab settles $30M kickback case, gets 5-year compliance agreement [Read](https://americanhealthintel.com/editions/2026-07-19-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#arkansas-pathology-kickback-30-million-cia) New Jersey pharmacy owner and technician sentenced for falsifying records to hide $1.1M fraud [Read](https://americanhealthintel.com/editions/2026-07-19-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#new-jersey-pharmacy-fraud-sentencing-patel-lugo) 177Records$16.0BEnforcement7Deadlines65Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-07-19-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |